RemeGen Co., Ltd. (HKG:9995)
Hong Kong
· Delayed Price · Currency is HKD 40.30
-0.90 (-2.18%)
May 16, 2025, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 26.73 billion as of May 16, 2025. Its market cap has increased by 11.76% in one year.
Market Cap
26.73B
Enterprise Value
28.88B
Revenue
2.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
40.30
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has decreased from 33.39B to 26.73B, a decrease of -19.96%. That is a compound annual growth rate of -4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 26.73B | 90.84% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 185.54B |
| Hansoh Pharmaceutical Group Company | 134.38B |
| JD Health International | 124.72B |
| WuXi Biologics | 96.87B |
| Alibaba Health Information Technology | 84.27B |
| Innovent Biologics | 82.39B |
| Akeso | 72.97B |
| Sino Biopharmaceutical | 69.79B |